This may be due to differences between cytoplasmic and nuclear IKKα\ IKKα isoform expressions, or that mutant KRAS induces wildtype BRAF signalling in CRC, resulting in p45-IKK signalling. This evidence concerns the gene KRAS and colorectal carcinoma.